Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Heart Failure PREVENT-HF: A Phase 2b Randomized Placebo-Controlled Carvedilol Trial

Brief Summary

Type:
Multiple Sites (Solid Tumors)

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT02717507

Study #:
CMH - ALTE1621

Start Date:
Dec 31, 2017

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02717507

View Complete Trial Details & Eligibility at ClinicalTrials.gov